ATM and neuroblastoma: Should the function of ATM be compromised in somatic cells, this can enable the acquisition of tumorigenic mutations, often seen in cancers including breast cancer (Moslemi et al., 2021), neuroblastoma (Southgate et al., 2020) and colorectal cancer (Randon et al., 2019).